Primate-plant mutualisms : is there evidence for primate fruit syndromes?

For over thirty years, researchers have identified the traits of “primate fruits” (fruits that are exclusively or primarily dispersed by primates). This book chapter reviews the primate fruit syndrome hypothesis in the history of primate seed dispersal studies. It addresses whether primate fruit syndromes exist in alignment with primates exerting sufficient selective pressure on plants via seed dispersal that alters the evolutionary trajectories of those plants. Because of recent technological advances that allow for the quantification of fruit traits, along with the importance of primates as seed dispersers, the fruit syndrome hypothesis can be tested.Canada Research Chairs ProgramNatural Science and Engineering Research Council of CanadaFonds Québécois de la Recherche sur la Nature et les Technologie

Risk Factors and Prediction of Long-term Outcome in Primary Biliary Cirrhosis

The natural history of the disease varies greatly among individual patients with primary biliary cirrhosis (PBC). Some patients live long without any symptoms while other patients present jaundice and develop hepatic failure in early phases of the disease. Previous studies showed that the natural course of PBC is altered by the use of ursodeoxy cholic acid (UDCA). In this review we discuss variation in the natural course of the disease and it\u27s alteration by UDCA, and risk factors that predict disease progression. Based on clinical observations, there are three types of clinical evolution in PBC: 1) minimal to slow progression over several years; 2) rapid progression to jaundice and hepatic failure, and 3) progression to portal hypertension without developing deep jaundice. Notably, based on our analyses accelerated progression to jaundice and liver failure are reflected by a sustained serologic presence of anti-gp210 antibodies whereas patients with portal hypertension in the absence of jaundice have anti-centromere autoantibodies. These observations highlight the clinical importance of antinuclear antibody analysis in patients with PBC